Analysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self protein D52-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self protein D52

Published:2019-11-26 Issue:6 Volume:16 Page:1413-1423
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Elizondo C. Riccay¹^ORCID,Bright Jennifer D.¹^ORCID,Byrne Jennifer A.²^ORCID,Bright Robert K.¹³^ORCID

Affiliation:

1. Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA

2. Faculty of Medicine and Health, The University of Sydney, Westmead, Australia

3. Cancer Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1689746

Reference44 articles.

1. Clinical evaluation of therapeutic cancer vaccines

2. Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?

3. Are oncoantigens suitable targets for anti-tumour therapy?

4. The Universal Character of the Tumor-Associated Antigen Survivin: Fig. 1.

5. Telomerase as a universal tumor antigen for cancer vaccines

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment;Journal of Functional Biomaterials;2024-08-16

2. Preclinical support for tumor protein D52 as a cancer vaccine antigen;Human Vaccines & Immunotherapeutics;2023-10-30

3. Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype;Human Vaccines & Immunotherapeutics;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3